LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Reiterates REVOLUTION MEDICINES, INC. (RVMD) At Outperform With $77 Price Target 10/17/2025 9:17:45 PM
  • FDA Grants Revolution Medicines CNPV Voucher For RAS(ON) Inhibitor Daraxonrasib 10/16/2025 8:41:24 PM
  • Revolution And Summit Partner On Clinical Studies For Solid Tumor Therapies 6/30/2025 8:49:33 AM
  • Wedbush Is Increasing REVOLUTION MEDICINES, INC. (RVMD) FY25 Estimate To -3.41 From -4.76 6/24/2025 8:46:39 PM
  • Wedbush Is Increasing REVOLUTION MEDICINES, INC. (RVMD) Q3 25 Estimate To 0.12 From -1.21 6/24/2025 8:46:19 PM
  • Wedbush Reiterates REVOLUTION MEDICINES, INC. (RVMD) At Outperform With $73 Up From $67 Price Target 6/24/2025 8:45:48 PM
  • Royalty Pharma And Revolution Medicines Enter Into Funding Agreements For Up To $2 Bln 6/24/2025 7:14:08 AM
  • Revolution Medicines’ Daraxonrasib Secures FDA Breakthrough Therapy Designation For KRAS G12-Mutant Metastatic PDAC 6/23/2025 9:06:50 AM
  • Wedbush Is Cutting REVOLUTION MEDICINES, INC. (RVMD) FY26 Estimate To -5.02 From -4.58 5/8/2025 11:19:05 AM
  • Wedbush Is Lowering REVOLUTION MEDICINES, INC. (RVMD) FY25 Estimate To -4.76 From -4.34 5/8/2025 11:18:44 AM
  • Wedbush Is Lowering REVOLUTION MEDICINES, INC. (RVMD) Q2 25 Estimate To -1.17 From -1.07 5/8/2025 11:18:33 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap